*  Import Data And Price Of Ifosfamide | www.eximpulse.com
IFOSFAMIDE. 25. KGS. 66421.39. 1660534.69. Chennai Air Cargo ACC. Duty. More 10. 16-Feb-16. 30049099. UNITED STATES. ( FOC ... IFOSFAMIDE STERILE USP (BULK DRUG M/F OF ANTICANCERINJECTION). 10. KGS. 70853.52. 708535.2. Delhi Air Cargo ACC. Duty. More ... IFOSFAMIDE 40MG/ML SOLUTION FOR INFUSION (2G/50ML). 9. VLS. 27402.86. 246625.74. Chennai Air Cargo ACC. Duty. More ... IFOSFAMIDE 40MG/ML SOLUTION FOR INFUSION (2G/50ML). 9. VLS. 27402.86. 246625.74. Chennai Air Cargo ACC. Duty. More ...
  https://www.eximpulse.com/import-product-ifosfamide.htm
*  Kidney Damage in Patients Receiving Cisplatin and Ifosfamide for Solid Tumors - Full Text View - ClinicalTrials.gov
Blood and urine samples are collected on days 1 and 2 (or day 3 if receiving ifosfamide only) during the first 3 courses. ... Kidney Damage in Patients Receiving Cisplatin and Ifosfamide for Solid Tumors. This study has suspended participant recruitment ... Ifosfamide. Antineoplastic Agents. Antineoplastic Agents, Alkylating. Alkylating Agents. Molecular Mechanisms of ... PURPOSE: This research study is evaluating kidney damage in patients receiving cisplatin and ifosfamide for solid tumors. ...
  https://clinicaltrials.gov/ct2/show/NCT00695032
*  Ifosfamide With or Without Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cancer of the Uterus - Full...
It is not yet known whether ifosfamide alone is more effective than ifosfamide plus paclitaxel in treating patients with cancer ... A Phase III Trial of Ifosfamide (NSC #109274) Versus Ifosfamide Plus Paclitaxel (NSC #125973) in Patients With Advanced, ... Ifosfamide With or Without Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cancer of the Uterus. This ... Drug Information available for: Ifosfamide Paclitaxel Genetic and Rare Diseases Information Center resources: Soft Tissue ...
  https://www.clinicaltrials.gov/ct2/show/NCT00003128
*  "N-acetylcysteine protects against ifosfamide nephrotoxicity" by Lauren Hanly
However, there is no data available to suggest the safe use of n-acetylcysteine with respect to maintenance of ifosfamide's ... To demonstrate the impact of n-acetylcysteine on the antitumor efficacy of ifosfamide, we evaluated the combination of n- ... acetylcysteine and ifosfamide mustard, the active antineoplastic agent in vitro and n-acetylcysteine and ifosfamide in a mouse ... This late effect is caused by oxidative damage, generated by chloroacetaldehyde, a toxic metabolite of ifosfamide cytochrome ...
  http://ir.lib.uwo.ca/etd/1483/
*  Sorafenib, Epirubicin, Ifosfamide, and Radiation Therapy Followed By Surgery in Treating Patients With High-Risk Stage II or...
Experimental: Sorafenib, Epirubicin, Ifosfamide Drug: epirubicin hydrochloride I.V., days 1-3 of each cycle. Epirubicin to be ... Sorafenib, Epirubicin, Ifosfamide, and Radiation Therapy Followed By Surgery in Treating Patients With High-Risk Stage II or ... Drug Information available for: Ifosfamide Epirubicin hydrochloride Epirubicin Sorafenib Sorafenib tosylate Genetic and Rare ... Drug: ifosfamide Over 90 minutes I.V., days 1-3 of each cycle. Administered with hydration and Mesna. ...
  https://clinicaltrials.gov/show/NCT00822848
*  Ifosfamide and Doxorubicin, Radiation Therapy, and/or Surgery in Treating Young Patients With Localized Soft Tissue Sarcoma -...
Patients then receive ifosfamide alone IV over 3 hours on days 1-3. Treatment with ifosfamide repeats every 21 days for 2 ... Ifosfamide and Doxorubicin, Radiation Therapy, and/or Surgery in Treating Young Patients With Localized Soft Tissue Sarcoma. ... Ifosfamide and Doxorubicin, Radiation Therapy, and/or Surgery in Treating Young Patients With Localized Soft Tissue Sarcoma. ... Group 2 (IRS group I, tumor , 5 cm): Patients receive ifosfamide IV over 3 hours on days 1-3 and doxorubicin hydrochloride IV ...
  https://clinicaltrials.gov/ct2/show/record/NCT00334854?cond=%22Malignant+fibrous+histiocytoma%22
*  Ifosfamide/mesna Side Effects in Detail - Drugs.com
Learn about the potential side effects of ifosfamide/mesna. Includes common and rare side effects information for consumers and ... if this side effect is promptly recognized and ifosfamide is immediately stopped.. Ifosfamide should be stopped in cases of ... The diagnosis of ifosfamide-induced hemorrhagic cystitis is based on (a) a history of gross hematuria; (b) laboratory findings ... Testicular Cancer cisplatin, etoposide, bleomycin, vinblastine, ifosfamide, Platinol, Toposar, dactinomycin, Velban, Cosmegen, ...
  https://www.drugs.com/sfx/ifosfamide-mesna-side-effects.html
*  Alquimid (Ifosfamide) Sanfer Laboratorios
Alquimid information about active ingredients, pharmaceutical forms and doses by Sanfer Laboratorios, Alquimid indications, usages and related health products lists
  http://drugs-about.com/drugs-a/alquimid.html
*  PharmaCyte Biotech Successfully Completes Multiple Course Ifosfamide Study | BioSpace
PharmaCyte Biotech Successfully Completes Multiple Course Ifosfamide Study - read this article along with other careers ... Because ifosfamide is a prodrug, by itself it is not toxic to cancer cells. Ifosfamide must be activated by cytochrome P450 ... The ifosfamide is carried by the circulatory system to where the encapsulated cells have been implanted. When the ifosfamide ... plus low doses of ifosfamide, only two courses of ifosfamide treatment were given to the patients. ...
  https://www.biospace.com/article/releases/pharmacyte-biotech-successfully-completes-multiple-course-ifosfamide-study/
*  Aranesp and Neulasta in Patients With Sarcoma Receiving Adriamycin and Ifosfamide
... in Patients With Sarcoma Receiving Adriamycin and Ifosfamide. Trial Phase:. N/A. Minimum Age:. 18 Years. Maximum Age:. 65 Years ... in Patients With Sarcoma Receiving Adriamycin and Ifosfamide ...
  http://www.knowcancer.com/cancer-trials/NCT00283621/
*  Ifosfamide and Doxorubicin in Patients With Refractory Nasopharyngeal Carcinoma - No Study Results Posted - ClinicalTrials.gov
Ifosfamide and Doxorubicin in Patients With Refractory Nasopharyngeal Carcinoma. The safety and scientific validity of this ...
  https://clinicaltrials.gov/ct2/show/results/NCT00484601
*  Docetaxel and Ifosfamide in Treating Women With Metastatic Breast Cancer - Full Text View - ClinicalTrials.gov
Docetaxel and Ifosfamide in Treating Women With Metastatic Breast Cancer. The safety and scientific validity of this study is ... Ifosfamide. Antineoplastic Agents. Tubulin Modulators. Antimitotic Agents. Mitosis Modulators. Molecular Mechanisms of ... Patients receive docetaxel IV over 1 hour on day 1 and ifosfamide IV over 1 hour (beginning 1 hour after docetaxel infusion) on ... PURPOSE: Phase II trial to study the effectiveness of docetaxel and ifosfamide in treating women who have metastatic breast ...
  https://clinicaltrials.gov/show/NCT00026078
*  Metastatic Secondary Fibrosarcoma of Bone Responsive to Repeated Courses of Ifosfamide and Associated With Hypoglycemia
Metastatic Secondary Fibrosarcoma of Bone Responsive to Repeated Courses of Ifosfamide and Associated With Hypoglycemia. Elaine ... the last three using the same dose/schedule of single agent ifosfamide. Eventual rapid progression of a huge intra-abdominal ...
  https://www.hindawi.com/journals/sarcoma/2003/193026/abs/
*  Ifosfamide - Wikipedia
Ifosfamide is given quickly, and in some cases can be given as quickly as an hour. Hemorrhagic cystitis is rare when ifosfamide ... Ifosfamide may also cause a normal anion gap acidosis, specifically renal tubular acidosis type 2. "Ifosfamide". The American ... ACS Drug Guide: Ifosfamide Harvard Medical School Health Information on Ifosfamide MedlinePlus Drug Information BC Cancer ... Ifosfamide (IFO), sold under the brand name Ifex among others, is a chemotherapy medication used to treat a number of types of ...
  https://en.wikipedia.org/wiki/Ifosfamide
*  Delayed rhabdomyolysis with paclitaxel, ifosfamide, carboplatin, and etoposide regimen: a case report
Paclitaxel and ifosfamide. TI-CE. Chemotherapy regimen, including paclitaxel (T), ifosfamide (I) carboplatin (C), etoposide (E) ... and ifosfamide for two cycles with some dose reduction of ifosfamide in cycle 4. His beta-human chorionic gonadotropin was ... ... Ifosfamide is thought to cause heart muscle damage more than skeletal muscular damage [15]. Rhabdomyolysis usually develops on ... The TIGER trial is a currently ongoing phase III trial designed to compare CDT (arm A, paclitaxel, ifosfamide, and cisplatin, ...
  http://pubmedcentralcanada.ca/pmcc/articles/PMC5387351/
*  Neoadyuvant High-dose of Ifosfamide and Concurrent Radiotherapy in Soft Tissue Sarcoma - No Study Results Posted -...
Neoadyuvant High-dose of Ifosfamide and Concurrent Radiotherapy in Soft Tissue Sarcoma. The safety and scientific validity of ...
  https://clinicaltrials.gov/ct2/show/results/NCT01102608
*  Ifosfamide / ifosfamide NDA 090181 global drug patent coverage, generic alternatives and suppliers
Additional details are available on the IFOSFAMIDE profile page. The generic ingredient in IFOSFAMIDE is ifosfamide; mesna. ... NDA 090181 describes IFOSFAMIDE, which is a drug marketed by Fresenius Kabi Usa, Mylan Labs Ltd, Teva Pharms Usa, and West-ward ...
  https://www.drugpatentwatch.com/p/NDA/090181
*  Salvage therapy in recurrent germ cell cancer: ifosfamide and cisplatin plus either vinblastine or etoposide
... Loehrer PJ, Lauer ... Ifosfamide combination chemotherapy as third-line or greater therapy can produce durable complete remissions in heavily ... To determine the efficacy of the addition of ifosfamide to cisplatin plus etoposide (VIP), or vinblastine (VeIP), in patients ... INTERVENTIONS: Patients were administered cisplatin (20 mg/m2 body surface area daily for 5 days), ifosfamide (1.2 g daily for ...
  https://imsdd.meb.uni-bonn.de/cgi-bin/mycite?ExtRef=MEDL/88339106/PMID/2844110
*  Phase I-II Trial of Sorafenib in Combination With Ifosfamide in Soft Tissue Sarcoma - Full Text View - ClinicalTrials.gov
Phase I-II Trial of Sorafenib in Combination With Ifosfamide in Soft Tissue Sarcoma. The safety and scientific validity of this ... Ifosfamide has also a well-established activity (1,2) and is often administered either associated with Doxorubicin or alone as ... Drug Information available for: Ifosfamide Sorafenib Sorafenib tosylate Genetic and Rare Diseases Information Center resources ... Ifosfamide. Niacinamide. Antineoplastic Agents. Protein Kinase Inhibitors. Enzyme Inhibitors. Molecular Mechanisms of ...
  https://clinicaltrials.gov/ct2/show/NCT00541840?term=sarcoma&
*  A Randomized Study of the Effect of Adjuvant Chemotherapy With Doxorubicin and Ifosfamide With Mesna in the Treatment of High...
Drug Information available for: Ifosfamide Mesna Doxorubicin Doxorubicin hydrochloride Genetic and Rare Diseases Information ... Ifosfamide. Mesna. Antibiotics, Antineoplastic. Antineoplastic Agents. Topoisomerase II Inhibitors. Topoisomerase Inhibitors. ... A Randomized Study of the Effect of Adjuvant Chemotherapy With Doxorubicin and Ifosfamide With Mesna in the Treatment of High- ... A Randomized Study of the Effect of Adjuvant Chemotherapy With Doxorubicin and Ifosfamide With Mesna in the Treatment of High- ...
  https://clinicaltrials.gov/ct2/show/NCT00001300?rank=8
*  Trial of Gemcitabine, Cisplatin, and Ifosfamide in Patients With Relapsed Non-Seminomatous Germ-Cell Tumors - Full Text View -...
Trial of Gemcitabine, Cisplatin, and Ifosfamide in Patients With Relapsed Non-Seminomatous Germ-Cell Tumors. The safety and ... Drug Information available for: Ifosfamide Cisplatin Gemcitabine Gemcitabine hydrochloride Genetic and Rare Diseases ... This is a prospective multicenter phase II trial of gemcitabine, cisplatin, and ifosfamide (GIP) in patients with relapsed non- ... A Prospective Multicenter Phase II Trial of Gemcitabine, Cisplatin, and Ifosfamide (GIP) in Patients With Relapsed Non- ...
  https://clinicaltrials.gov/ct2/show/NCT00127049